← Eichor
Condition: Primary Bilary Cirrhosis Pbc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Bilary Cirrhosis Pbc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755151A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · 186 location(s) · Ipsen · NCT06016842Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Biochemical Response and Clinical Outcomes in Patients With PBC
Phase N/A · 1 location(s) · RenJi Hospital · NCT07449793Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · 205 location(s) · Gilead Sciences · NCT06051617RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis
NA · 1 location(s) · Hospital Clinic of Barcelona · NCT07161245Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755541Biobank for Cholestatic Liver Diseases.
Phase N/A · 1 location(s) · Mayo Clinic · NCT03445585An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
Phase 2/Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06365424Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
EARLY_Phase 1 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT07104201Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Chol
Phase 1/Phase 2 · 40 location(s) · Umecrine Cognition AB · NCT07304843LEOPARD Training and Validation Data Collection Study
Phase N/A · 22 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06675604Swiss Primary Biliary Cholangitis Cohort Study
Phase N/A · 13 location(s) · Fondazione Epatocentro Ticino · NCT03146910FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT07296458PBC Long-term Outcomes Study
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT07149675Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
Phase N/A · 1 location(s) · Asociación Española para el Estudio del Hígado · NCT06767605Detection Program for Patients With Primary Biliary Cholangitis Lost in the System
Phase N/A · 1 location(s) · Hospital Mutua de Terrassa · NCT05919433Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Mag
Phase 3 · 3 location(s) · Zydus Therapeutics Inc. · NCT07216235National Database on Primary Biliary Cholangitis
Phase N/A · 55 location(s) · University of Milano Bicocca · NCT05151809Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
Phase 4 · 1 location(s) · Peking Union Medical College Hospital · NCT04650243Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)
Phase N/A · 2 location(s) · University of Aarhus · NCT04514965Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
Phase 3 · 7 location(s) · Xijing Hospital of Digestive Diseases · NCT05751967A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Pr
Phase 2 · 130 location(s) · Mirum Pharmaceuticals, Inc. · NCT05050136Canadian Network for Autoimmune Liver Disease
Phase N/A · 15 location(s) · University Health Network, Toronto · NCT03569826Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and N
Phase N/A · 1 location(s) · Hospital Universitario La Paz · NCT07205874sCD163 in PBC Patients - Assessment of Treatment Response
Phase N/A · 1 location(s) · University of Aarhus · NCT02931513
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.